Genetic screening for oral human papillomavirus infections and cancers of the head and neck

Clinical Cancer Research

Volumn 14, Issue 21, 2008, Pages 6723-6724

  Sok, John C ^a   Grandis, Jennifer R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN; RIBONUCLEOPROTEIN; SODIUM CHLORIDE; TELOMERASE; WART VIRUS VACCINE; VIRUS DNA;

CANCER RISK; CARCINOGENESIS; CELL CYCLE PROGRESSION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE MUTATION; GENE SILENCING; GENETIC SCREENING; HEAD AND NECK CARCINOMA; HUMAN; LABORATORY TEST; MORBIDITY; MOUTH CAVITY; MOUTH INFECTION; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEXUAL TRANSMISSION; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; SUPPRESSOR GENE; VIRUS INFECTION; GENETICS; HEAD AND NECK TUMOR; MOUTH DISEASE; NOTE; OROPHARYNX TUMOR; VIROLOGY;

DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH DISEASES; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 58149214376     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1915     Document Type: Short Survey

References (12)

1. Agrawal Y, Koch WM, Xiao W, et al. Oral HPV infection before and after treatment for HPV16-positive and negative head and neck squamous cell. Clin Cancer Res. In press. 2008.
2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: cancer incidence and mortality worldwide. IARC CancerBase no.5, version 2.0. Lyon (France): IARC; 2004.
3. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626-36.
4. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
5. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinma of Waldeyer's tonsillar oring. Cancer 1997;79:595-604.
6. Steenbergen RD, Hermsen MA, Walboomers JM, et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55:5465-71.
7. Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996;56:5720-2.
8. Spafford MF, Koch WM, Reed AL, et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607-12.
9. López M, Aguirre JM, Cuevas N, et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients a diagnostic and/or prognostic tool? Eur J Cancer 2003;39:2306-9.
10. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
11. Muñoz N, Bosch FX, de Sanjosé S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
12. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-9.